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Abstract
(9R)-9-hydroxystearic acid (9R-HSA) has been proven to have antitumoral activity because it
is shown to inhibit histone deacetylase 1, an enzyme which activates DNA replication, and the
(R)-enantiomer has been shown to be more active than the (S )-enantiomer both in vitro and
by molecular docking. Hydroxyapatite is the main mineral component of bone and teeth and
has been used for over 20 years in prostheses and their coating because it is biocompatible and
bioactive. The goal of incorporating 9R-HSA into hydroxyapatite is to have a material that
combines the bioactivity of HA with the antitumoral properties of 9R-HSA.
In this work, 9R-HSA and its potassium salt were synthesized and the latter was also in-
corporated into hydroxyapatite. The content of (9R)-9-hydroxystearate ion incorporated into
the apatitic structure was shown to be a function of its concentration in solution and can reach
values higher than 8.5%. (9R)-9-hydroxystearic acid modified hydroxyapatite was extensively
characterized to determine the effect of the incorporation of the organic molecule. This incor-
poration does not significantly alter the unit cell but reduces the size of both the crystals as
well as the coherent domains, mainly along the a-axis of hydroxyapatite. This is believed to
be due to the coordination of the negatively charged carboxylate group to the calcium ions
which are more exposed on the (100) face of the crystal, therefore limiting the growth mainly
in this direction. Further analyses showed that the material becomes hydrophobic and more
negatively charged with the addition of 9R-HSA but both of these properties reach a plateau
at less than 5% wt of 9R-HSA.
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1 Introduction
1.1 Cell Cycle and Tumors
The cell cycle (Figure 1) is the series of events that lead up to cell division. Generally it is
split into two main phases: mitotic (M) phase, where the actual splitting of the cells occur, and
the interphase, where the cell grows and the DNA is replicated. The interphase is considered
to be split into 3 phases, two gap phases called G1 and G2, where cell growth occurs and
many proteins are synthesized, separated by a phase called S (Synthesis) phase where the DNA
replication occurs. There is also another gap phase called G0 where the cell leaves the cycle and
arrests its division permanently or temporarily. Between these phases there are checkpoints
that control the passing of the cell between one phase and the other. The most important ones
for cell division are the G1/S and G2/M between those respective phases.
1
Figure 1: General scheme of the cell cycle. It is split into interphase (I) and mitotic (M) phase,
the interphase is further split into gap phases (G1 and G2) and synthesis (S) phase.
A tumor or neoplasm is tissue resulting from an abnormal growth of the cells. This growth
is greater and not coordinated to that of the surrounding normal tissue. Neoplasms can be
benign or malignant and in this last case are called cancer or tumors.
Tumor cells have uncontrolled growth because the control mechanisms that avoid replication
of damaged cells stop working. This is almost always due to a change in one or more genes,
changing the function of the proteins they produce, resulting in faulty cell cycle control. This
usually can be seen as a problem with the genes relative to the two checkpoints.1
p53 is a protein that is shown to be mutated or inactive in many tumor cells. It is activated
when the cell recognizes stressors like DNA damage, oxidative stress and oncogene expression.
It is related to many pathways with anti-cancer functions: activate DNA repair, arrest the cell
cycle at the G1/S checkpoint and initiate apoptosis. One of these pathways is by activating
the expression of the p21WAF1 protein. This protein binds to cyclin dependent kinases (CDK)
necessary for the G1/S transition. The effect of 9-hydroxystearic acid on these pathways has
been a subject of recent research.2–4
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1.2 9-Hydroxystearic Acid
9-Hydroxystearic acid (9-HSA, Figure 2) is an organic fatty acid. In this work it is synthesized
from the unsaturated dimorphecolic acid, also known as, (9S,10E,12E )-9-hydroxyoctadeca-
10,12-dienoic acid. Dimorphecolic acid (Figure 3) is the main fatty acid found in Dimorphotheca
sinuata L. seeds (Figure 4) amounting to about 65% of the total fatty acids found in the seeds
of this genus.5
OH
O
OHH
Figure 2: 9R-Hydroxystearic Acid or (9R)-R-hydroxyoctadecanoic acid.
OH
O
OHH
Figure 3: Dimorphecolic acid or (9S,10E,12E )-9-hydroxyoctadeca-10,12-dienoic acid.
Figure 4: Dimorphotheca sinuata L. flowers (left) and seeds(right). The seeds have a high
dimorphecolic acid content.
9-HSA is known to derive from lipid peroxidation and believed to be recognized by the cell
as a sign of external stress. The synthesis is done by extraction of the oil from the seeds because
this is the only source of enantiomerically pure 9R-HSA. Attempts have been made to find a
different enantioselective synthesis pathway, chiefly through enzymatic kinetic resolution but
these have been proven difficult due to the high symmetry of the molecule.6 A racemic mixture
of 9-HSA can be produced after hydrolysis of the methylester, starting from commercially
available mono-methylazelate, by the pathway shown in Figure 5.7
9-HSA is a byproduct of lipid peroxidation. Lipid peroxidation is caused by radical reactions
like those triggered by reactive oxygen species that are formed during cellular respiration. It is
a mechanism for the deterioration of fats and oils within cells and generally is seen in cellular
8
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Figure 5: Reaction scheme for the synthesis of methyl (R,S )-9-hydroxystearate.
membranes. Peroxidized lipids can become more hydrophilic, diffuse to other parts of the cell
and cause damage farther from the source. In tumor cells the intermediates of lipid peroxidation,
as well as the polyunsaturated fatty acid content in membrane lipids, are reduced. It has been
shown that lipid peroxidation products stall cell proliferation and can induce cell death.8 Since
9-HSA is a lipid byproduct that is seen in lower quantities in tumor cells, it was an interesting
molecule to test for its anti-tumor activities.
Figure 6: Binding of 9R-HSA to zinc-dependent human HDAC1 protein.9
A few studies of 9-HSA on different cell lines have been carried out. Firstly, in C108, a
murine Lewis lung carcinoma cell line, 9-HSA and 10-HSA were isolated and proven to exist in
mammalian cells.10 In the T leukemia cell line Jurkat J6 (J6)9-HSA was able to elicit Activation
Induced Cell Death (AICD) in concentrations above 10 µM by activation of caspase 3. At 5
µM no significant apoptosis was detected but significant inhibition of proliferation due to an
increase in the percentage of cells in G0/G1 and a decrease in S phase. This was said to be due
9
to changes in the expression of cyclin D3 and hypophosphorilated pRB.2
Most studies were done with HT29, a human colon adenocarcinoma cell line. One of the
particularities of this cell line is that it has a mutated inactive p53 gene so experiments with
this cell line indicate a p53-independent pathway. 9-HSA is shown to be cytostatic in HT29
in a pathway that depends on p21WAF1 because this result is not observed in the p21WAF1-
deleted HCT116 human colon carcinoma cells.11 It causes the arrest of the cell cycle in G1
phase. In another study4 it was shown to act as a HDAC1, HDAC2, HDAC3 inhibitor. Histone
deacetylase 1 (HDAC1) deacetylates lysine groups on chromatin, allowing it to bind more
strongly to DNA and stimulate DNA synthesis, therefore histone deacetylase inhibitors are
interesting as prospective anti-tumor drugs. 9-HSA induces in this cell line an increase of
p21 transcription and lower expression of cyclin D1,4 which is known to regulate the G1/S
transition. A docking experiment (Figure 6) showed that 9-HSA binds to HDAC1 and that the
R-enantiomer is more active than the S -enantiomer.9 This was also confirmed in cells.4
It has been shown in U2OS, a human osteosarcoma line with an active p53 gene, that 9-
HSA also affects p53 by inducing hyperacetylation due to its HDAC1 inhibitory activity. This
induces apoptosis by a mitochondrial pathway.3
1.3 Hydroxyapatite
Hydroxyapatite or hydroxylapatite (HA, Figure 7) is a mineral from the apatite group of phos-
phates presenting the formula Ca10(PO4)6(OH)2. The other common members of this group
include chlorapatite (Ca10(PO4)6Cl2) and fluorapatite (Ca10(PO4)6F2).
Figure 7: Simplified structure of hydroxyapatite. Ca(I) (in blue) form columns parallel to
the c-axis and Ca(II) (in yellow) are the vertices of staggered equilateral triangles around the
screw axis. Oxygens are shown in green and phosphorus in orange. Hydrogens are omitted for
simplicity but are found along the screw axis.12
When compared to other calcium phosphates, HA is the most stable13 and with one of the
the highest Ca/P ratio. Stoichiometric HA has a Ca/P ratio of 1.67. Decreasing the Ca/P ratio,
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even in mixed materials, results in higher solubility of the calcium phosphate in a physiological
environment.14
HA has two known crystalline forms. The first one is monoclinic and crystallizes in the P21/b
space group.15 The most important form is the hexagonal form which the crystal structure was
published by Kay in 1964.16 It belongs to the P63/m space group with unit cell parameters
a = b = 9.432Å, c = 6.881Å, α = β = 90◦ and γ = 120◦.17 This space group is characterized
by its symmetry elements: a sixfold screw axis parallel to the c-axis with a period of 1
2
and two
mirror planes parallel to the ab plane that intersect the c-axis at the 1
4
and 3
4
positions. The
calcium ions occupy two different independent cation sites, usually named Ca(I) and Ca(II).
Ca(I) atoms form a column parallel to the c-axis. Ca(II) form the walls of “channels” along
the screw axis, at the vertices of staggered equilateral triangles (Figure 7). The hydroxide ions
are aligned within the screw axis, with random directions with respect to the c-axis.
There are several synthetic methods to produce HA in the literature, these differ in the
reaction conditions and are usually classified as two main methods. The first one consists of a
titration of a calcium hydroxide suspension with phosphoric acid until neutrality.18 In the sec-
ond, the precipitation method, a monobasic sodium or ammonium phosphate is added dropwise
to a calcium containing solution (usually calcium acetate or nitrate).19 Both methods produce
products with high crystallinity when carried out at 100◦. The lowering of the temperature
produces an increase of the amount of amorphous material present, therefore, reducing the
crystallinity. The precipitation method must be kept basic (pH > 9) during the synthesis, usu-
ally by the addition of sodium hydroxide or ammonia, favoring the precipitation of HA instead
of other calcium phosphates. Reaction time also affects the crystallinity and average crystallite
size. If the reaction time is too short the product tends to be nanocrystalline with a large
amorphous portion and as it increases, the crystallinity improves.13 The synthesis is usually
carried out under nitrogen, because in air the incorporation of carbonates is significant (and
further reduces crystallinity). Finally, apatites, like other calcium phosphates, can be obtained
from metastable phosphates in aqueous solution.20
The incorporation of divalent cations, anions like F–, Cl–, CO3
2– or other molecules can alter
several of hydroxyapatite’s physicochemical properties, including the cell parameters, morphol-
ogy and size of the crystals, amount of amorphous material, thermal stability and solubility.21
However, the main interest in HA is due to its role in the structure of bone and teeth. HA
is the main mineral constituent of bone (70% wt) and teeth (96% wt) usually with a small
amount (4–6%) of carbonate being exchanged with the phosphate groups in the structure.22
HA has been used for over 20 years as dense bioceramics, porous bioceramics, coating for
implants or as a powder for gap fillings.23 HA promotes osteointegration, particularly in its
use as a coating for metallic implants.24,25 The degree of integration depends on the ability of
the material to imitate the characteristics of natural bone, including composition, surface and
mechanical properties. Its use in prosthetics is particularly interesting within the scope of this
work because in many cases the treatment of osteosarcoma includes bone resection and cancer
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recurrence is a possible complication.26 Another possible complication is bacterial infection on
the prosthesis and composite materials that include antibiotics27,28 or silver nanoparticles,29–31
for their broad antibiotic properties, have been prepared.
1.4 Spectroscopic and Spectrometric Methods
1.4.1 Nuclear Magnetic Resonance
Nuclear Magnetic Resonance (NMR) spectrometry is an absorption spectrometry, much like
Infrared and Ultraviolet spectrometries. The wavelength used is in the microwave region.
Spin and orbital angular momenta give rise to magnetic moments. Classically the energy
of a magnetic moment µ in a magnetic field B0 is given by Equation 1 and the quantum
mechanical equivalent Hamiltonian is equation 2. The magnetic moment operator can be
further decomposed and in the case of the nuclear spin to give equation 3 where γN is called
the gyromagnetic ratio and l̂ is the angular momentum operator.32
E = −µB0 (1)
Ĥ = −µ̂B0 (2)
µ̂ = γN l̂ (3)
Because the eigenvalues for l̂ are ~mI the Hamiltonian can be solved to give rise to Equation
4 where mI is the value spin magnetic moment. In the absence of an external magnetic field
states with different values of mI are degenerate.
E(mI) = −γN~mIB0 (4)
Under a magnetic field, different values of nuclear spin lose their degeneracy. The splitting is
called the nuclear Zeeman Effect (Figure 8). This energy difference is usually in the microwave
region of the electromagnetic spectrum and this transition is what is observed in an NMR
spectrum. The magnitude of the splitting of a certain nucleus is not only dependent on the
external magnetic field but actually on the local effective magnetic field. The difference between
the external field and the effective field is termed chemical shift and is of major importance when
using NMR for organic synthesis. Chemical shift arises from the movement of electrons within
the sample, induced by the external magnetic field. Since this movement is an electrical current,
it creates a smaller local magnetic field which in turn changes the value of the magnetic field
effectively “seen” by a particular nucleus. Chemical shift contains information on the chemical
environment and can be associated with chemical functions in proximity of the nucleus, for
example.
Another important phenomenon present on a NMR spectrum is the splitting. One particular
type of splitting, J-splitting, is commonly used for attributions in organic spectra. This splitting
is caused by a slight difference in energy depending on whether the nucleus is aligned or opposed
12
Figure 8: Zeeman Effect: Splitting of the energy levels for a I=1/2 system like 1H or 13C.
to the electrons around it. Since it is due to the local fields created by neighboring magnetic
moments it is independent of the external magnetic field, therefore is usually expressed as a
frequency (in Hz).
Current routine NMR is done with a setup as shown in Figure 9.
Figure 9: Scheme of a NMR machine using a superconductive magnet.33
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The main parts are the superconductive electromagnet, the probe and the console. The
electromagnet is made up of metal wires wrapped around the probe in a solenoid coil and this
produces a homogeneous magnetic field in the sample. The metal wires are cooled down to 4
K to achieve super conductivity using liquid helium. The liquid helium bath is surrounded by
vacuum and liquid nitrogen, to avoid evaporation and heat transfer. The probe is the part that
produces the radiofrequency pulse that will excite the spins and that detects the precession of
the spins. It contains a solenoid of wires, called shim coil, perpendicular to the main magnetic
field that is necessary for the pulse and that receives the induced current from the precession
motion. The console includes parts of the machine necessary for signal processing. The signal
produced by the equipment is called a Free Induction Decay (FID) and must be decomposed
into its constituent frequencies by Fourier Transform (FT) to obtain the typical NMR spectrum.
1.4.2 X-Ray Diffraction
Peter Paul Ewald and Max Laue realized in 1912 that crystals could be used as diffraction
grating as long as the wavelengths used were shorter than visible light, in the X-Ray portion
of the electromagnetic spectrum to be exact. This is because for diffraction to occur, the
electromagnetic radiation should be of the same order of magnitude as the spacing in the
grating and typical spacing between atoms in a crystal is about 2-3Å. Photons hitting atoms in
a crystal will scatter as a wave around the atom and by interacting with the photons scattered
by other atoms interference occurs. Most interference is destructive but in few directions the
interference is constructive. These directions are given by Bragg’s Law (equation 5), where λ
is the wavelength of the X-rays being scattered, d is the distance between atomic planes, θ the
incident angle and n a positive integer. The reason for this can be seen in Figure 10.32
nλ = 2dsinθ (5)
In the case of a monocrystal, an intense beam of X-rays is directed onto the crystal and causes
Figure 10: Schematic proof of the Bragg’s Law. At a given angle θ, the difference in path
length of the X-ray to reach the next plane of atoms is given by 2d sinθ.
a diffraction pattern made up of discrete points which can be recorded using photographic film,
a point detector or an area detector like a charge-coupled device (CCD). The intensity of these
14
points contains information on the motif (nature and position of the atoms) while the position
of these points contain information on the unit cell or the matrix of the crystal.34
In this work, crystalline powder X-ray diffraction will be used. The powder is made up of many
very small crystals with random orientation As a consequence, the position of the diffraction
spots changes for each crystallite and the resulting diffraction is composed of circles instead
of points. This is usually represented as a diffractogram taken radially (Figure 11). Each
peak contains all the families of planes with the same interplanar distance d, this is called the
multiplicity of the peak. For example, cubic unit cells have the same interplanar distances in
several directions (d100, d010 and d001) and will show all of these planes as a single peak.
Figure 11: NaCl powder X-ray diffraction pattern.35
Powder X-ray diffraction is not commonly used for structure determination but is a pow-
erful technique for phase characterization and identification. Comparison to databases of pure
substances, like the International Centre for Diffraction Data’s database,36 can be used to de-
termine the materials contained in an unknown mixture of materials.
Within a diffractogram, the value of 2θ can be used to determine the unit cell parameters,
the intensity of the peaks can be used to determine the structure and for quantitative analysis
and the peak width carries information about the crystallite size and micro-straining. Since
amorphous materials do not have long-range order but might have local order, they affect the
background of the diffractogram.
There are different geometries that can be used to obtain powder X-ray diffraction diffrac-
tograms. In this work, the PANanalytical X’PERT Pro X’Celerator powder diffractometer uses
Bragg-Brentano geometry with a θ-θ configuration (Figure 12). In this geometry the sample is
fixed and the source and detector move together to always be both at a θ angle with respect
to the sample. In this way the detector is 2θ with respect to the incident beam, collecting the
diffracted X-ray beam, following Bragg’s law. Bragg-Brentano geometry can also be achieved
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Figure 12: Bragg-Brentano geometry for X-ray powder diffraction. Top shows the relationship
between the angles in this geometry. Below, the two possible configurations, where the sample
is fixed and the X-ray tube is fixed, respectively.
by having a fixed source and have the sample and detector move, keeping the 2θ relationship
between the 3 components.
1.4.3 Transmission Electron Microscopy
Transmission Electron Microscopy (TEM) is a technique where a beam of electrons pass through
a very thin sample. The electron beam interacts with the sample as it goes through. This
interaction is dependent on the atomic number of the elements present in the sample, heavier
elements interact more often with the electrons and appear as dark shadows on a TEM image.
High-speed electrons from the electron beam can collide with inner shell electrons, which can
cause the following phenomena: (1) a lower energy electron can be ejected (secondary electron);
(2) the original electron is scattered (back-scattered electron); (3) an outer shell electron drops
into the position formerly occupied by the ejected electron, from which an X-ray photon of the
precise wavelength of the energy difference is emitted.
TEM detects the decrease in the electron beam caused by the first two phenomena. Scan-
ning Electron Microscopy (SEM) detects the secondary and back-scattered electrons, while the
analysis of the X-ray photon emitted is used in X-ray microanalysis.
Transmission electron microscopes are capable of higher resolution than optical microscopes
due to their small deBroglie wavelength, when compared to visible light used in optical micro-
scopes. Because of this, this technique is used to visualize objects of micro and nano-meter
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scales.
The microscopes have 4 main parts (Figure 13). The electron gun is the source of electrons.
Figure 13: Comparison of an optical microscope with a transmission electron microscope.
It is usually composed of a tungsten filament that with a current passing through generates a
flow of electrons. Secondly, a system of magnetic lenses (as opposed to optical lenses) focus the
electron beam onto the target. The sample is usually prepared on a copper grid covered with a
non-absorbing film. Finally the image is projected onto a phosphorescent viewing screen that
glows when struck by electrons.37
2 Objective
9-HSA is known to be active against osteosarcoma.3 The aim of this work is to functionalize
hydroxyapatite (HA) with 9-HSA to obtain a bioactive material that combines the biocompat-
ibility of HA toward bone with the cytostatic and/or cytotoxic properties of 9-HSA.
To achieve this objective, in this work potassium (9R)-9-hydroxystearate, the more water
soluble salt of 9R-HSA, was synthesized from Dimorphotheca sinuata L. seeds and included in
the direct synthesis of hydroxyapatite. The precursors and the novel materials were character-
ized by a series of techniques.
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3 Experimental Methods
3.1 Materials
The Dimorphotheca sinuata L. seeds were bought from Galassi sementi SNC at Gambettola
(FC, Italy). The reagents used, unless stated otherwise were acquired from Sigma-Aldrich
(Milan). Flash chromatography was done with a silica gel (0.037-0.063 mm, Merck) station-
ary phase. Thin layer chromatography (TLC) was done with silica gel 60 from Fluka An-
alytical and the spots were revealed using an aqueous solution of (NH4)6MoO24 (2.5%) and
(NH4)4Ce(SO4)4 (4%) in 10% H2SO4.
For the hydrogenation reaction a Parr hydrogenator model 3911EKX is used with a hydrogen
gas pressure of 40 psi.
3.2 Characterization
The nuclear magnetic resonance spectra (1H, 13C, DEPT) were obtained using Varian spectrom-
eters Gemini 300, Mercury 400 and Inova 600 (Varian, Palo Alto). All spectra were obtained
using either CDCl3, DMSO-d6 or D2O as the solvent. The frequencies are given in Hz and the
chemical shift δ in ppm using the chemical shift of CHCl3 as the reference (δ = 7.26 ppm in
1H-NMR and δ = 77.0 ppm in 13C-NMR).
Gas chromatographic analyses were carried out with a Hewlett-Packard (HP) 5890 gas
chromatograph directly interfaced with an Agilent 5970 mass selective detector. Injection
temperature was 250◦C (split injection mode split ratio 50:1) (HP-5MS column, 30 m, 0.25
mm, 0.25 µm film thickness). The oven temperature was programmed as follows: 60◦C for 2
min, increased up to 260◦C at the rate of 20◦C/min, followed by 260◦C for 20 min. The carrier
gas was helium, used at a flow rate of 1 mL/min; the transfer line temperature was 280◦C;
the ionization was obtained by electron impact (EI), acquisition range was 50–500 m/z. EI
mass spectra were recorded using a VG-7070E spectrometer at an ionization voltage of 70 eV.
ESI-MS spectra were recorded on a WATERS 2Q 4000 instrument.
Fourier Transform Infrared (FT-IR) spectra of the organic compounds were recorded using a
Perkin-Elmer FT-IR MOD 1600 spectrophotometer. FT-IR spectra of hydroxyapatite and 9R-
HSA modified HA were recorded using a Bruker Alpha FT-IR in both ATR and transmission
modes. For measurements taken in transmission mode the samples were prepared by grinding
1 mg of the material with 250 mg of potassium bromide and pressing the mixture into a pellet
with a pressure of 10 tons per square inch during one minute.
Melting points were measured by a Büchi apparatus and were not corrected.
Thermogravimetric analysis was carried out using a Perkin Elmer TGA-7. Heating was
performed in a platinum crucible in air flow (20 cm3 min−1) at a rate of 10◦C min−1 up to
950◦C. The samples weights were in the range 5–10 mg.
X-ray diffraction patterns were obtained using a PANanalytical X’PERT Pro X’Celerator
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powder diffractometer using copper Kα characteristic radiation (λ = 1.5418 Å) and selected
using a graphite monochromator, with a fixed divergent slit of 1
4
◦
and a fixed anti-scatter slit of
1
2
◦
. Acquisitions were taken using three different scan programs: (1) Diffractograms obtained
for crystalline phase identification were measured from 2θ =10◦ to 60◦ with 0.10◦ per step and
a 0.128◦/s scan rate. The analysis is qualitative and done by comparison to the diffractograms
from the International Centre for Diffraction Data (ICDD) database.36 (2) The cell parameters
were determined using a lattice parameter refinement software called CELSIZ,38 that uses the
information from a series of reflections after the Miller indices have been attributed. The
diffractograms for this determination are obtained from scans measured from 2θ =10◦ to 60◦
with 0.05◦ per step at a scan rate of 0.04◦/s. Crystalline silicon was added as an internal
standard and appears in the diffractograms as thin peaks at 28.443◦, 47.304◦ and 56.122◦. (3)
Data was collected from all the samples relative to the 002 and 310 reflections for crystal size
determination. The scan intervals chosen were 24.5◦–27.5◦ and 38.0◦–41.0◦, for each reflection
respectively. These were obtained with a step of 0.008◦ and a scan rate of 0.016◦/s. The
results were treated with the data treatment program MARQFIT39 to obtain the half width
at half maximum (HWHM). This value was corrected for instrumental broadening using the
experimental value of the HWHM of silicon reflections (1
2
βSi = 0.04
◦).
Transmission Electron Microscopy (TEM) was used to obtain information on crystal size
and morphology. After being ground, hydroxyapatite crystals were dispersed in ethanol by
ultrasound for 30 s. A drop of the suspension was added to the Formvar-covered copper grid
and subsequently dried in air. The grid was analyzed using a Philips CM100 transmission
electron microscope at 80 kV.
Contact angle measurements were done using a CAM 101 equipment. Pure HA and HSAHA
were pelletized with 8 tons per square inch during two minutes. Pellets acted as the solid phase
for the measurement, milliQ water was used as the liquid phase air as the third phase. Data
was acquired with the KSV Contact Angle Measurement system software, by taking 3 frames
per second during 30 s after the drop was set on the surface. Values obtained were an average
of 5 drops.
Zeta potential measurements were done using Dynamic Light Scattering (Zetasizer Nano;
Malvern Instruments). The samples were prepared by suspending 5 mg of powder 50 mL of
MilliQ water after sonication for 2 minutes.
The specific surface area was measured using a Carlo Erba Sorpty 1750 BET analyzer using
constant volume N2 absorption with desorption at 80
◦C. All surface area measurements were
obtained with 0.5 g of solid sample.
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3.3 Synthesis of (9R)-9-hydroxyoctadecanoic acid
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Figure 14: Scheme of the (9R)-9-hydroxystearic acid synthesis from Dimorphotheca sinuata L.
seeds.
3.3.1 Extraction of oil from Dimorphotheca sinuata L. seeds
12 g of Dimorphotheca sinuata L. seeds were ground and added to a three-necked round-bottom
flask and stirred under nitrogen with 210 mL of CHCl3/MeOH (2:1) for 24h. This suspension
was filtered under vacuum and washed with CHCl3 (3 x 20 mL). The solution was acidified
with 20 mL of 0.1 M HCl and 0.1 M NaCl aqueous solution and then extracted with CHCl3 (3
x 15 mL). The organic layers were combined and dried over anhydrous MgSO4. After filtration,
the yellow solution was dried in vacuo at 30◦C to obtain 4.0 g of yellow oil.
3.3.2 Transesterification of the oil from Dimorphotheca sinuata L.
The yellow oil was dissolved in 40 mL MeOH and treated with 1 M (2.16 g) of NaOCH3 and
stirred under N2 atmosphere at 0
◦C for 2h. The resulting solution was acidified to pH 5.0
(presents color change from green to yellow) and extracted with n-hexane (3 x 20 mL). The
hexane layers were combined and dried over anhydrous MgSO4 and, after filtration, the solvent
was removed under reduced pressure to give 2.2 g of oil.
3.3.3 Hydrogenation of the esterified oil
The bright yellow oil was dissolved in 10 mL of ethyl acetate and transferred to a 500 mL
reaction bottle with a catalytic amount of PtO2 (Adam’s catalyst). This mixture was subjected
to hydrogenation in a Parr apparatus with 40 psi H2 pressure for 35 min. The resulting solution
was filtered over celite and the solution concentrated under vacuum. A 1H NMR spectrum is
obtained to confirm the absence of vinylic hydrogens before proceeding.
Flash chromatography (petroleum ether / diethyl ether 7:3) of the residue gave methyl (9R)-
9-hydroxyoctadecanoate as a white solid (0.743g). (m.p.: 50-51.2◦C)
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1H NMR (399.9 MHz, CDCl3, TMS): 3.65 (s, 3H, OCH3), 3.60-3.55 (m, 1H, CHOH), 2.29 (t,
2H, J = 7.6 Hz, CH2COO), 1.61 (quint, 2H, J = 7.4 Hz, CH2CH2COO), 1.50-1.20 (m, 27H,
incl. OH), 0.87 (t, 3H, J = 7.0 Hz, CH3).
13C NMR (100.6 MHz, CDCl3): 174.1, 71.7, 51.3, 37.4, 37.3, 33.9, 31.8, 29.6, 29.56, 29.5, 29.4,
29.2, 29.1, 28.9, 25.5, 25.4, 24.8, 22.6, 14.05.
The attribution of the 13C NMR signals are reported in Annex B.
IR(CHCl3): 3427, 1728 cm
−1.
3.3.4 Hydrolysis of methyl (9R)-9-hydroxyoctadecanoate
To obtain (9R)-9-hydroxyoctadecanoic acid 0.300 g of methyl (9R)-9-hydroxyoctadecanoate
was stirred in 20 mL of a 10% w/v methanolic solution of KOH for 12h at room temperature.
The reaction was monitored by TLC. The solvent was removed under vacuum and the light
yellow solid was dissolved in water and acidified until precipitation. This mixture was extracted
with ethyl acetate and after this was dried with anhydrous MgSO4 and, after filtration, the
solvent was removed under vacuum. (9R)-9-hydroxyoctadecanoic acid (9R-HSA) was then re-
crystallized from methanol to give 0.232 g of white acicular crystals. (m.p. 74.5-78.2◦C from
methanol, literature:40 76-77◦C) 1H NMR (399.9 MHz, CDCl3, TMS): 4.73 (broad s, 1H, OH),
3.53-3.63 (m, 1H, CHOH), 2.34 (t, 2H, J = 7.4 Hz, CH2COO), 1.63 (quint, 2H, J = 7.1 Hz,
CH2CH2COO), 1.49-1.16 (m, 27H, incl. OH), 0.88 (t, 3H, J = 7.0 Hz, CH3).
13C NMR (100.6 MHz, CDCl3, TMS): 178.7, 72.0, 37.5, 37.4 33.5, 31.9, 29.7, 29.6 (two over-
lapped signals), 29.4, 29.3, 29.2, 29.0, 25.7, 25.5, 24.7, 22.7, 14.1.
3.3.5 Synthesis of the potassium (9R)-9-hydroxyoctadecanoate
2.022 g of 9R-HSA was dissolved in a equimolar KOH/methanol 5% solution and left stirring
for 3h. The reaction was monitored by TLC and once completed the methanol was dried under
vacuum. The resulting light yellow solid was dissolved in 10 mL of boiling water, left to cool
to room temperature, finally, the precipitate was filtered and removed, the resulting mother
liquor was dried under vacuum at 45◦C. 1.561 g of potassium(9R)-9-hydroxyoctadecanoate were
obtained as a light yellow powder from the mother liquor.
3.4 Derivatization of 9-HSA with (R)-(-)-O-acetylmandelic acid
OH
O
O
O
OCH3
O
78
OH
OCH3
O
78
O
O
O
DMAP, DCC
CH2Cl2
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The optical purity of methyl (9R)-9-hydroxyoctadecanoate was determined by 1H NMR
analysis after derivatization with (R)-(–)-O-acetylmandelic acid using the following procedure:
0.010 g of (R)-(–)-O-acetylmandelic acid and 0.002 g of DMAP were dissolved, under nitrogen
gas, in 300 µL of anhydrous CH2Cl2 and stirred at 0
◦C (ice-bath). To this solution, a solution
of 0.008 g of methyl (R)-9-hydroxystearate and 0.010 g of DCC in 500 µL of anhydrous CH2Cl2
was added. After a few minutes a white solid precipitated and the reaction was monitored by
TLC (eluent: n-hexane – AcOEt 3:1) until it resulted complete. The product was purified by
preparative TLC (eluent: n-hexane – AcOEt 3:1) and the spot with RF 0.6 was scraped.
The product was dissolved in methanol and the suspension was filtered. After removal of the
solvent, the product was dissolved in CDCl3 and
1H NMR spectroscopy at 600 MHz showed
only one signal corresponding to H-2 signal of the mandelic moiety (on the racemic mixture
the signals of H-2 of the mandelic moiety, as well as those of OCH3 signals of the ester moiety,
resulted to be satisfactorily separated). The same observation was made by 1H NMR analysis
of the crude reaction mixture prior its purification by preparative TLC.
The spectra of the diastereotopic products have been reported4 and present the following
peaks:
Methyl (9R)-9-[(2R )-2-(acetyloxy)-2-phenylacetyl]oxyoctadecanoate: 1H NMR (599.7 MHz,
CDCl3): 7.51-7.44 (m, 2H, phenyl), 7.40-7.34 (m, 3H, phenyl), 5.874 (s, 1H, H-2), 4.88 (quint,
1 H, J = 6.36 Hz, H-9), 3.671 (s, 3H, OCH3), 2.30 (t, 2H, J = 7.55 Hz, CH2CO), 2.19 (s, 3H,
OCOCH3), 1.68-1.00 (m, 28 H, CH2), 0.89 (t, 3H, J = 6.8 Hz, CH3).
Methyl (9S )-9-[(2R )-2-(acetyloxy)-2-phenylacetyl]oxyoctadecanoate: 1H NMR (599.7 MHz,
CDCl3): 7.51-7.47 (m, 2H, phenyl), 7.42-7.37 (m, 3H, phenyl), 5.870 (s, 1H, H-2), 4.86 (quint,
1 H, J = 6.36 Hz, H-9), 3.667 (s, 3H, OCH3), 2.27 (t, 2H, J = 7.55 Hz, 2H, CH2CO), 2.19 (s,
3 H, OCOCH3), 1.68-1.00 (m, 28H, CH2), 0.88 (t, 3H, J = 6.9 Hz, CH3).
The 1H NMR spectroscopy at 600 MHz showed two signals at 3.670 and 3.666 ppm cor-
responding to the R and S derivatives of methyl 9-hydroxystearate respectively with a ratio
of 9 to 1, indicating an enantiomeric ratio of about 90:10 of methyl (9R)-9-hydroxystearate.
This ratio was confirmed also by considering another diagnostic signal, i.e. that belonging to
the H-2 proton of the mandelic moiety of the HSA derivative. Also for this signal there is a
detectable chemical shift difference between the two diastereomers (5.868 and 5.872 ppm for
R-9 and S -9 derivative, respectively). The presence of two diastereoisomers might be due to
the derivatization method and therefore other methods are currently being tested.
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3.5 Synthesis of crystalline hydroxyapatite
3.5.1 Preparation of decarbonated water
2 L of distilled water are heated in a round bottom flask with a condenser under nitrogen. The
water is refluxed during one hour and cooled under nitrogen in an ice bath. It can then be
transferred into flasks previously purged with nitrogen and should be used within 5 days.
3.5.2 Hydroxyapatite synthesis
Ca(NO3)2 . 4H2O
(NH4)2HPO4
H2O, pH 10
90°C, N2, 5h
Ca10(PO4)6(OH)2
In a 500 mL three-necked round-bottom flask 50 mL of 0.64 M diammonium hydrogen
phosphate (4.29 g in decarbonated water) was heated with magnetic stirring with a condenser
under nitrogen to 90◦C. Once the temperature is reached, 25% ammonia solution is added to
adjust the pH to 10. To this flask 50 mL of 1.08 M calcium nitrate tetrahydrate (12.75 g in
decarbonated water), also adjusted to pH 10 with a 25% ammonia solution, was added slowly
at a rate of approximately 3 mL/min. Once the addition was finished, ammonia is added to
adjust the pH to 10. The reaction is kept under heating for 5 h, periodically verifying the
temperature and pH and adjusting as necessary. Once completed it is cooled under nitrogen
gas then washed three times with 90 mL decarbonated water, each time centrifuging at 10000
rpm for 10 min. Finally, the white powder was dried overnight at 37◦C.
3.6 Synthesis of (9R)-9-hydroxystearic acid modified hydroxyap-
atite
The synthesis of 9HSA-modified hydroxyapatite is done with the same method as the synthesis
of HA with the inclusion of 5 , 10, 15 and 20 mmol.L−1 of potassium (9R)-9-hydroxystearate
(Table 1). Each concentration was done in duplicate. The solid was added to the round-
bottom flask prior to the addition of calcium nitrate tetrahydrate and mixed and heated until
the solution was homogeneous. The addition of calcium nitrate started only after the complete
dissolution of 9R-HSA-K.
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Table 1: Samples subjected to absorption of potassium (9R)-9-hydroxystearate.
Sample Amount of 9R-HSA-K (mg) [9R-HSA] (10−3 mol.L−1)
HSAHA 5 170 5
HSAHA 10 340 10
HSAHA 15 510 15
HSAHA 20 680 20
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4 Results and Discussion
4.1 Synthesis of methyl (9R)-9-hydroxystearate
(9R)-9-hydroxystearic acid was obtained by hydrogenation of dimorphecolic acid isolated from
Dimorphotheca sinuata L. seeds. This procedure was chosen because of the interest in the
enantiomerically pure (9R)-9-hydroxystearic acid due to its increased HDAC1 activity when
compared to the S-enantiomer in simulations9 and in cells.4
To obtain 9R-HSA the triglycerides were extracted from Dimorphotheca sinuata L. seeds
then transmethylated, both under nitrogen gas to avoid eventual oxidation of the double bonds
in dimorphecolic acid. For sake of clarity Figure 14, already reported in the experimental part,
is reported again in this section. Successively, the mixture containing several fatty acid esters
from the seeds is hydrogenated in a Parr apparatus using PtO2 as a heterogeneous catalyst.
This reaction was also tested with 10% carbon-supported palladium (Pd/C) as an attempt to
check if the reduction step can affect the configuration of the C-9 nevertheless this reaction
presented lower yield with similar enantiopurity of the final product. At this step a 1H-NMR
spectrum is obtained to verify if the hydrogenation is complete. This is done by seeing that
there are no more vinylic hydrogens in the 5-6 ppm region. Once the reaction completion is
confirmed the fatty acid esters are separated by flash chromatography and only methyl (9R)-
9-hydroxystearate is kept.
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Figure 14: Scheme of the (9R)-9-hydroxystearic acid synthesis from Dimorphotheca sinuata L.
seeds.
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4.1.1 Nuclear Magnetic Resonance Spectrometry
The resulting 1H-NMR spectrum of methyl (9R)-9-hydroxystearate is shown in Figure 15. In
OCH3
O
OHH
Figure 15: 1H-NMR spectrum of methyl (9R)-9-hydroxystearate.
this spectrum the most notable peak is the intense singlet at 3.65 ppm that integrates for 3H
and is attributed to the ester methoxy hydrogens. The presence of the close electronegative
oxygen is what make this signal the most deshielded on the spectrum. Beside this peak, a broad
multiplet between 3.63 and 3.53 ppm is seen. This integrates for 1H and is attributed to the
hydrogen on the same carbon as the hydroxyl group, which is why it is so deshielded as well.
The splitting is not very well defined at this field strength but is expected to be dddd because
all the hydrogens 3 bonds away from it form two diastereotopic pairs. At 2.29 ppm there is a
triplet that integrates for 2H. This chemical shift is expected for a pair of hydrogens beside an
ester carbonyl, much less deshielded than the methoxyl group, but more than a typical aliphatic
chain. At 1.61 ppm there is a quintet that is most likely on the β-carbon from the carbonyl.
It is actually a dddd since all hydrogens are diastereotopic but it appears as a quintet because
the J-coupling values are so similar. Unfortunately, between 1.50 and 1.20 ppm the bulk of
the hydrogens are found but the overlapping at this field does not allow to distinguish them.
Here are all 27 remaining hydrogens, including that of the hydroxyl group. Finally, at 0.87
ppm, the most shielded peak with an integration of 3H is the methyl group at the end of the
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long aliphatic chain and appears as a triplet because the two diastereotopic hydrogens on the
neighboring carbon both cause the same J-splitting.
4.1.2 Mass Spectrometry
The mass spectrum of methyl (9R)-9-hydroxystearate (Figures 16, 17 and 18) was obtained by
electron impact (EI-MS). The molecular ion is not present in this spectra. We do see the typical
M+-31 at m/z = 283, the release of a methoxy radical, characteristic of a methyl ester. The
base peak in this spectrum is m/z = 155, the breaking of a aliphatic bond α to the hydroxyl
group on carbon 9. This is proof that the acid is indeed methyl 9-hydroxystearate and not
another methyl hydroxystearate.
OCH3
OOH
43
57
71
283
155
159 129
115
101
87
73
Figure 16: Main cleavage positions seen on the mass spectrum of methyl 9-hydroxystearate.
Figure 17: Electron Impact Mass Spectrum of methyl 9-hydroxystearate.
Other visible peaks in this mass spectra include the cleavage of the aliphatic chain after the
hydroxyl group with the charge remaining on the smaller fragment (m/z = 43, 57), sometimes
forming the CnH2n−1 fragment (m/z = 41, 55, 69, 83)
41 and of the chain between the carbonyl
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Figure 18: Enlargement of the Mass Spectrum of methyl 9-hydroxystearate near the molecular
ion.
and the chiral center (m/z = 73, 87, 101, 115, 129, 159). We see the peak corresponding to a
sequential rearrangement that results in the loss of water and methanol (m/z = 264) and an
intense peak when the chain breaks on the other bond α to the hydroxyl at m/z = 187. The
rearrangement that releases 1-nonanol (m/z = 158) is also a very intense peak.
4.2 Derivatization of 9-HSA with (R)-(-)-O-acetylmandelic acid
The enantiomeric purity of the methyl ester of 9-HSA was determined by derivatization using
(R)-(-)-O-acetyl mandelic acid because due to its high symmetry, methyl (9R)-9-hydroxystearate
is only slightly levorotatory ([α25D ]= -0.18
◦, c 10.0, ethanol)42 making determining the enan-
tiomeric ratio by optical methods difficult. The reaction used is a soft method for acylating
alcohols43 and has been used for separating alcohol enantiomers for over 30 years.44 This
reaction was done with methyl (9R)-9-hydroxystearate instead of (9R)-9-hydroxystearic acid
because there would be competing reactions in the mixture. DCC in the presence of a catalytic
amount of DMAP would cause the hydroxyl group to attack all acids in solution, both the
desired (R)-(-)-O-acetyl mandelic acid and other 9R-HSA molecules resulting in an even more
complex mixture of products.
Figure 20 shows the two peaks found in the spectrum that correspond to the methoxy
hydrogens in both (R)-methyl 9-((R)-2-acetoxy-2-phenylacetoxy)octadecanoate and (S )-methyl
9-((R)-2-acetoxy-2-phenylacetoxy)octadecanoate (Figure 19) and by comparing their areas the
28
enantiomeric ratio was found to be approximately 90:10 for the R-enantiomer of methyl (9R)-
9-hydroxystearate. The rest of the spectrum is not shown and interpreted because the NMR
tube contains the whole of the reaction medium including excess reagents used in the reaction.
Purification is not necessary to reach the necessary information, also, during the purification by
flash chromatography some amount of one of the two diastereoisomers might not be completely
collected, thus giving an erroneous result.
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Figure 19: Diastereoisomers formed in the derivatization of 9-HSA with (R)-(-)-O-acetyl man-
delic acid.
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Figure 20: Enlargement of the NMR spectrum of 9-HSA derived with (R)-(-)-O-acetylmandelic
acid showing the ester methoxyl hydrogens of both diastereoisomers.
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4.3 Synthesis of (9R)-9-hydroxystearic acid
9R-HSA is produced by converting the methyl ester into the potassium salt by reacting it with
a large excess of potassium hydroxide in methanol. This reaction can be accompanied by TLC
where the methyl ester will disappear but the potassium salt does not run in organic solvents.
Once complete, which can take as little as 3 h or as much as 12 h, the reaction is acidified and
some precipitation can be seen. This is extracted in ethyl acetate and isolated.
4.3.1 Nuclear Magnetic Resonance
The resulting 1H-NMR spectrum is shown in Figure 21. The attribution of the NMR spectrum
of 9R-HSA is very similar to that of the methyl ester. The main differences are the absence
of the methoxy group and the appearance of an acid OH broad peak at 4.73 ppm but whose
exact position varies from one experiment to another. All other peaks were attributed like the
methyl ester and did not show significant changes in the chemical shift.
OH
O
OHH
Figure 21: 1H-NMR spectrum of (9R)-9-hydroxystearic acid.
4.3.2 Thermogravimetric Analysis
For comparison reasons, 9R-HSA was analyzed by thermogravimetric analysis (Figure 22). It
showed complete decomposition of the acid before 600◦C.
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Figure 22: Thermogravimetric analysis of (9R)-9-hydroxystearic acid.
4.3.3 Mass Spectrometry
The mass spectrum of (9R)-9-hydroxystearic acid (Figures 24 and 25) was obtained by electron
impact (EI-MS). The molecular ion is not present in this spectra, as is expected for a long-
chain carboxylic acid. We do see the typical M+-17 at m/z = 283, the loss of the terminal OH,
characteristic of a carboxylic acid. The base peak in this spectrum is m/z = 155, the breaking
of a aliphatic bond α to the hydroxyl group on C-9. This is proof that the acid is indeed
9-hydroxystearic acid and not another hydroxystearic acid. Other visible peaks (Figure 24)
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Figure 23: Main cleavage positions seen on the mass spectrum of 9-hydroxystearic acid.
in this mass spectra include the cleavage of the aliphatic chain after the hydroxyl group with
the charge remaining on the smaller fragment (m/z = 43, 57, 71, 99, 127), sometimes forming
the CnH2n−1 fragment (m/z = 41, 55, 69, 83, 97)
41 and of the chain between the carbonyl and
the chiral center (m/z = 45, 59, 73, 87, 101, 115). We also see a peak caused by two sequential
loses of water at m/z = 264. The rearrangement that releases 1-nonanol appears at m/z = 144.
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Figure 24: Electron impact mass spectrum of 9-hydroxystearic acid.
Figure 25: Enlargement of the Mass Spectrum of 9-hydroxystearic acid around the molecular
ion.
4.4 Synthesis of potassium (9R)-9-hydroxystearate
To include 9R-HSA in the synthesis of hydroxyapatite it needed to be water soluble. As expected
from an 18-carbon chain fatty acid, it was not soluble in its acid form therefore several salts
32
of 9R-HSA were prepared using stoichiometric quantities of the metal hydroxide in methanol,
isolated as solids and tested towards their solubility in water. Sodium (9R)-9-hydroxystearate
proved to be a particularly insoluble salt, not dissolving readily in any pure solvent, only a
small amount was dissolved in dimethyl sulfoxide (DMSO-d6) to obtain an NMR spectrum
and confirm its purity. Both the potassium and ammonium salts of 9R-HSA proved to be
more readily dissolved in water, especially once heated above 85◦C. Since potassium (9R)-9-
hydroxystearate (9R-HSA-K) was the more water soluble of the two it was chosen to be used
in the HA synthesis.
4.4.1 Nuclear Magnetic Resonance
Due to solubility the 1H NMR spectrum of potassium (9R)-9-hydroxystearate the spectrum was
obtained in D2O instead of CDCl3 (Figure 26). The attribution of this spectrum is analogous
to (9R)-9-hydroxystearic acid without the presence of the broad hydroxyl proton resonance.
Figure 26: 1H-NMR spectrum of potassium (9R)-9-hydroxystearate.
4.4.2 Mass Spectrometry
The mass spectrum of potassium (9R)-9-hydroxystearate was obtained using Electron Spray
Ionization (ESI) mass spectrometry because this technique is a soft ionization technique which
permits the visualization of the molecular ion, which cannot be seen under harsher ionization
conditions. The negative mode was used to observe the presence of the organic anion. The
main peak at m/z = 299 is the conjugate base of 9R-HSA. The smaller peak at m/z = 149
represents the double salt, a doubly deprotonated form of 9R-HSA.
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Figure 27: ESI Mass spectrum obtained for potassium (9R)-9-hydroxystearate.
4.5 Synthesis of crystalline hydroxyapatite
Crystalline hydroxyapatite (HA) was synthesized by precipitation in a basic aqueous solution
using Ca(NO3) · 4 H2O and (NH4)2HPO4. The choice of calcium nitrate over calcium chloride
was shown to produce more a more crystalline product and avoid chloride incorporation in the
crystal structure.13 Hydroxyapatite was prepared by the slow addition of (NH4)2HPO4 onto
Ca(NO3)2 · 4 H2O. This produced 5.46 g of hydroxyapatite as a white powder with a yield of
98%.
4.5.1 Fourier-transform infrared spectrum
The experimental transmission Fourier-transform infrared (FT-IR) spectrum of hydroxyapatite
is shown in Figure 29. It shows the characteristic infrared resonances pertaining to HA, as
summarized in Table 2 (vide infra). One of the main absorption bands of HA is the thin band
at 3569 cm−1 due to the O-H stretching within the apatitic structure, its intensity is related to
the crystallinity of the material and is much less intense, sometimes even completely masked
by the water band, in the case of carbonated apatite.45 Theoretically the phosphate groups
would present 4 IR active modes: symmetric stretching υ1, asymmetric stretching υ3, symmetric
bending υ2 and asymmetric bending υ4. Due to the presence of OH groups the phosphate ion
is not of perfect Td symmetry υ3 and υ4 are split into more than one band.
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4.5.2 X-ray diffraction pattern
The X-ray diffraction pattern of hydroxyapatite is shown in Figure 28. Data was normalized
setting the most intense peak (31.81◦) as 100%. Parameters of the unit cell can be determined
from the powder X-ray diffraction pattern. Hydroxyapatite crystallizes in a hexagonal unit cell
and the relationship between the Miller indices (hkl) and the distance d between planes is given
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by Equation 6. Using Bragg’s Law (Equation 5) this relationship becomes Equation 7 which
relates the experimental diffraction angle θd and the Miller indices. With the Miller indices
attributed to each Bragg reflection the lattice parameters a, b and c (a = b in a hexagonal space
group) can be determined.
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Figure 28: X-ray diffraction pattern of hydroxyapatite.
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The Miller indices of hydroxyapatite were attributed13 to the experimental reflections (Annex
A) and the calculated cell parameters were a = b = 9.422 Å and c = 6.881 Å.
4.6 Synthesis of (9R)-9-hydroxystearic acid modified hydroxyap-
atite
The traditional direct synthesis13,19 of hydroxyapatite is usually done with the slow addition
of (NH4)2HPO4 onto heated Ca(NO3) · 4 H2O. 9R-HSA-K should be added to the ammonium
phosphate so that it is also slowly put into contact with the calcium ions. Initially this method
was tested but proved to be unfeasible due to the precipitation of 9R-HSA-K in the addition
funnel. The solution to this problem was the heating of ammonium phosphate and 9R-HSA-K
with the slow addition of calcium nitrate.
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4.6.1 Fourier-Transform Infrared spectrum
The infrared spectrum of (9R)-9-hydroxystearic acid modified hydroxyapatite (Figure 29, Table
2) is very similar to that of HSA with the addition of the most intense bands of potassium (9R)-
9-hydroxystearate, notably the C-H stretching in the region between 2982 and 2823 cm−1 and
the C=O stretching at 1551 cm−1. The frequency of the C=O stretching is shifted towards lower
wavenumbers than in 9R-HSA suggests that the acid is completely deprotonated, presenting
the same frequency seen as in 9R-HSA-K.
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Figure 29: Infrared spectrum of hydroxyapatite with the addition of 0, 10 and 20 mM of
(9R)-9-hydroxystearic acid.
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Table 2: Infrared Absorption Spectroscopy Data for hydroxyapatite and (9R)-9-hydroxystearic
acid modified hydroxyapatite.
Peak assignments HA (cm−1) HSA-HA (cm−1)
HA Hydroxyl stretch (m) 3569 3560
H2O hydroxyl stretch (vb) 3700–3000 3700-3000
9R-HSA-K C-H stretch – 2982–2823
Atmospheric CO2 2394–2284 2391–2281
Carbonate υ3 (m)
45 1635 1632
9R-HSA-K C=O stretch – 1551
Carbonate υ3 (m)
45 1486 1487
Carbonate υ3 (m)
45 1442 1442
Phosphate υ3 (vs)
45 1101 1096
Phosphate υ3 (vs)
45 1037 1032
Phosphate υ1 (m)
45 962 962
Carbonate υ2 (ms)
45 873 872
Phosphate υ4 (m)
45 633 633
Phosphate υ4 (vs)
45 602 603
Phosphate υ4 (vs)
45 566 564
Phosphate υ2 (w)
45 475 472
(vs) very strong, (ms) medium strong, (m) medium, (w) weak, (vb) very broad
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4.6.2 X-ray diffraction pattern
The X-ray diffraction pattern of (9R)-9-hydroxystearic acid modified hydroxyapatite (Figure
30) is similar to that of hydroxyapatite without notable shift, suggesting that the lattice pa-
rameters are maintained with the addition of 9R-HSA-K to HA. A slight broadening of the
peaks is visible, suggesting that the crystal size of the modified HA is reduced.
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Figure 30: Comparison between X-ray diffraction patterns for hydroxyapatite and (9R)-9-
hydroxystearic acid modified hydroxyapatite.
From the diffraction pattern the cell parameters obtained are shown in Table 3. A slight
increase of a from 9.422 Å to 9.431 Å can be appreciated, however it is too small to be con-
sidered relevant because the increase in width of the peaks made measurement of their precise
positions difficult. c remained essentially unchanged at 6.881 Å. Large changes in unit cell
parameters would suggest incorporation of (9R)-9-hydroxystearic acid within the cell lattice,
which probably does not happen due to 9R-HSA’s large size. Since there is not a considerable
change in the cell parameters there is no change in the cell volume.
Average crystallite size or coherent domain length (τhkl) can be determined using the Scher-
rer equation47 (Equation 8) assuming that the microstrain is negligible.
τhkl =
kλ
β cos θ
(8)
where λ is the wavelength of the incident radiation (1.5418 Å for Cu Kα radiation), θ is the
Bragg angle of the reflection being analyzed (half the value of 2θ), β is the full width at
half maximum, twice the half width at half maximum that was obtained from the MARQFIT
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Table 3: Cell parameters of hydroxyapatite and (9R)-9-hydroxystearic acid modified hydrox-
yapatite determined by X-ray diffraction.
Sample a (Å) c (Å) Unit Cell Volume (Å3)
HA 9.422(2) 6.881(2) 529.2(1)
HSAHA 5 9.426(3) 6.883(2) 529.7(3)
HSAHA 10 9.431(3) 6.880(2) 529.8(2)
HSAHA 15 9.431(2) 6.881(2) 530.1(3)
HSAHA 20 9.430(2) 6.880(2) 529.8(3)
program. k is a constant that depends on the particle shape. It can vary from 0.7 to 1.7
and is usually 0.9 for hydroxyapatite. To obtain the corrected values of β, the instrumental
broadening is corrected with the HWHM found experimentally for crystalline silicon (0.04◦)
using Equation 9. The error of τhkl (E) can be calculated using Equation 10 where δ 1
2
is the
error of the measurement of the HWHM.
β 1
2
corr =
√
β 21
2
− β 21
2
Si
(9)
E =
δ 1
2
β 1
2
corr
· τhkl (10)
Coherent crystalline domain lengths are shown in Table 4. The increase of the width of the
Bragg reflections with the increase of the concentration of potassium (9R)-9-hydroxystearate
suggests that the average dimensions of the crystals decrease (Figure 31). The decrease is more
pronounced for the (310) dimension of the crystallites, which decreases by 29.0% in size, while
the already longer (002) length of the crystallites only decreases by 16.6% in size. This shows
an anisotropy in the adsorption of the acid onto hydroxyapatite, a preference for the surfaces
perpendicular to the c-axis, whose growth are inhibited, as has been reported for the synthesis
of HA modified with acidic amino acids.48
Table 4: Coherent domain length τhkl determined by X-ray diffraction.
Reflection 002 Reflection 310
Sample 1
2
β (◦) 1
2
βcorr (
◦) β (◦) τ (Å) 1
2
β (◦) 1
2
βcorr (
◦) β (◦) τ (Å)
HA 0.0803(8) 0.0696(8) 0.1392 615(4) 0.194(2) 0.190(2) 0.3797 421(2)
HSAHA 5 0.0842(8) 0.0741(8) 0.1482 578(3) 0.194(2) 0.190(2) 0.3878 412(2)
HSAHA 10 0.0780(7) 0.0670(7) 0.1339 640(3) 0.222(2) 0.218(2) 0.4367 366(2)
HSAHA 15 0.858(7) 0.0757(7) 0.1514 566(3) 0.264(2) 0.261(3) 0.5219 306(2)
HSAHA 20 0.0926(7) 0.0835(7) 0.167 513(2) 0.270(3) 0.267(3) 0.5340 299(2)
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Figure 31: Average crystallite size (τ) measured from the (002) and (310) reflections as a
function of the concentration of 9R-HSA-K in the synthesis.
4.6.3 Thermogravimetric analysis
The thermogravimetric analysis of (9R)-9-hydroxystearic acid modified hydroxyapatite (Figures
32 and 33) showed three regions of mass loss. The first one between room temperature and
200◦C is the loss of absorbed water molecules and corresponds to about 2% of the mass of the
material. The second mass loss, between 200◦C and 600◦C can be attributed to the mass loss of
HA (pure HA loses approximately 2.5%) and the mass of 9R-HSA associated with HA (9R-HSA
decomposes completely before 600◦C). The third mass loss, between 700◦C and 900◦C is due
to the loss of carbon dioxide gas, due to incorporated carbonate and is always less than 0.5%
in weight. Table 5 shows that the amount 9R-HSA associated to hydroxyapatite increases up
to 8.58% as a function of its concentration in solution.
Table 5: Thermogravimetric analysis of (9R)-9-hydroxystearic acid modified hydroxyapatite as
a function of the concentration of 9R-HSA-K in the synthesis.
Sample First mass loss (wt%) Second mass loss (wt%) Amount of HSA (wt%)
HA 1.9720 2.4655 0
HSAHA 5 1.8375 4.5413 2.0758
HSAHA 10 2.1295 6.8643 4.3988
HSAHA 15 1.8314 8.9956 6.5301
HSAHA 20 1.8978 11.0462 8.5807
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Figure 32: Thermogravimetric analysis of (9R)-9-hydroxystearic acid modified hydroxyapatite.
Increasing concentrations of 9R-HSA-K are shown: 0 mM (black), 5 mM (green), 10 mM (blue),
15 mM (magenta) and 20 mM (red).
Figure 33: Differential thermal analysis of (9R)-9-hydroxystearic acid modified hydroxyapatite.
Increasing concentrations of 9R-HSA-K are shown: 0 mM (black), 5 mM (green), 10 mM (blue),
15 mM (magenta) and 20 mM (red).
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Figure 34: Increase of the second mass loss in the TGA as a function of the added amount of
9R-HSA-K. This shows a linear relationship and that no plateau was reached.
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4.6.4 Transmission Electron Microscopy
Transmission Electron Microscopy grids were prepared for samples HA, HSAHA 10 and HSAHA
20. Images are shown in Figure 35.
Figure 35: Transmission Electron Microscopy images of HA (a, b); HSAHA 10 (c,d) and
HSAHA 20 (e,f). All scale bars represent 200 nm.
Table 6: Average crystal dimensions determined by Transmission Electron Microscopy.
Sample Length (nm) Width (nm) Length to Width ratio
HA 215 65 3.3
HSAHA 10 142 28 5.2
HSAHA 20 68 13 5.2
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No amorphous material was seen in the TEM images. Pure HA crystals present average
dimensions of 215 nm by 65 nm (Table 6). There is a significant decrease in crystal size to 68
nm by 13 nm with the addition of 20 mM of hydroxystearic acid to the reaction. The slight
change in synthesis method (slowly adding calcium nitrate to ammonium phosphate as opposed
to the contrary) does not significantly change the morphology or size of the pure hydroxyapatite
crystals. Incorporation of (9R)-9-hydroxystearic acid increases the length to width ratio of the
crystals suggesting that there is a preferred adsorption surface for the acid, inhibiting growth
on that surface. Assuming the length (longer dimension) of the crystal is parallel to the c-axis
of the unit cell, the acid adsorbs on the (100) surface of the crystal. This is in agreement with
previous studies48–50 that show that organic acids preferentially adsorb onto the (100) surface
where calcium ions are more accessible to coordination by the carboxylate group.
4.6.5 Contact Angle Measurement
Contact Angle is a type of measurement obtained to determine the wettability of a surface
with respect to a specific liquid. In the case of water, a wettable surface is termed hydrophilic
and a non-wettable surface is called hydrophobic. The measurement is done by adding a drop
of the liquid to a flat surface and determining the angle where the liquid/air interface meets
the solid surface. The value of the contact angle reflects the relative strength of the molecular
interactions between the liquid/air and liquid/solid interfaces.51 Since in all our measurements
the liquid and air was kept the same, a change in the value of the contact angle represents a
change in the molecular interactions at the liquid/solid interface.
Hydroxyapatite is very hydrophilic and therefore shows a very low contact angle (as shown
in Figure 36: 0.33 s after the drop has touched the surface its contact angle is 7◦ and by 4
s water has been totally spread on the surface of the material. Even a low concentration of
(9R)-9-hydroxystearic acid causes a huge change in the liquid/solid molecular interactions of
this surface. The contact angle increases to 69◦ with 5 mM of 9R-HSA and once 10 mM have
been added, the contact angle reaches a maximum of about 91◦. In all samples containing
9R-HSA the surface contact angle was constant during the 30 s of acquisition. Samples with a
surface contact angle of 90◦ or more are considered to be hydrophobic.
This experiment shows that the hydrophobic tails of 9R-HSA are what is on the surface
of the material, in agreement with the idea that the charged carboxylate head is interacting
with the calcium ions in hydroxyapatite. It is not known how the increased hydrophobicity will
affect the material’s activity but there are examples in the literature that show that osteoblast
adhesion is increased with the decrease of the wettability.52–54
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Figure 36: Contact Angle measurements for HA (a), HSAHA 5 (b), HSAHA 10 (c), HSAHA
15 (d) and HSAHA 20 (e). The contact angle rapidly increases with the addition of 9R-HSA,
but reaches a maximum at HSAHA 10.
Table 7: Values of the contact angle for hydroxyapatite and (9R)-9-hydroxystearic acid modified
hydroxyapatite taken 0.33s after the contact of the water droplet.
Sample Contact Angle (◦)
HA 7
HSAHA 5 69
HSAHA 10 91
HSAHA 15 93
HSAHA 20 92
45
4.6.6 Zeta potential determination
In a colloidal solution one factor that affects the lability of particles is the presence of charge
on their surface. Ions of opposite charge tend to cluster nearby forming a layer called the
interfacial double layer, due to the presence of ions of both charges organizing themselves
around the particle. The inner layer of ions is non-mobile with respect to the particle and the
radius of this rigid layer is called the ‘shear radius’. The electric potential at the shear radius
is what is known as the zeta potential or electrokinetic potential.32
Electrophoresis is used to determine the zeta potential of a charged particle because the zeta
potential is related to the mechanical force applied on the particle when there is a difference of
potential applied to it.55 The zeta potential gives a relative quantification of the charge on the
surface of the particle, as well as the sign of this charge.
Table 8: Zeta potential for hydroxyapatite and (9R)-9-hydroxystearic acid modified hydroxya-
patite.
Sample Zeta Potential (mV)
HA -12.5
HSAHA 5 -17.8
HSAHA 10 -19.0
HSAHA 15 -20.4
HSAHA 20 -20.6
The zeta potential becomes more negative with the addition of 9R-HSA (Table 8), in agree-
ment with the idea that the negatively charged carboxylate binds to the positively charged
Ca2+ ions on the surface of HA. The zeta potential does not grow linearly with the increase
of the amount of 9R-HSA and seems to be reaching a maximum at around -21 mV. Increased
charge on the surface of HA has been shown to improve osteobonding in dog bone.56,57
4.6.7 Specific surface Area Measurement
Specific surface area is determined by the physical adsorption of a gas on the surface of a solid.
The volume of gas adsorbed corresponding to a monomolecular layer is what is determined by
the equipment and can be converted to area.
The values of the specific surface area for HA, HSAHA 5, HSAHA 10, HSAHA 15 and
HSAHA 20 are shown in Table 9. The variation obtained in the measurements are within
experimental error (10%) and therefore we cannot conclude from this experiment that there is
a significant change in the surface area. The materials present a surface area of 49±5 m2/g.
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Table 9: Specific surface area of hydroxyapatite and (9R)-9-hydroxystearic acid modified hy-
droxyapatite.
Sample Surface Area (m2/g)
HA 56
HSAHA 5 48
HSAHA 10 42
HSAHA 15 48
HSAHA 20 50
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5 Conclusions
(9R)-9-hydroxyoctadecanoic acid or (9R)-9-hydroxystearic acid (9R-HSA) was successfully pre-
pared by conversion of dimorphecolic acid, a fatty acid contained in high concentration in Di-
morphotheca sinuata L. seeds. Once the fatty acids belonging to the seed’s triglycerides have
been transesterified to the methyl esters, unsaturated fatty acids, including methyl dimorpheco-
late, are reduced with H2 using Adam’s catalyst PtO2 and separated from the other methyl
esters by column chromatography. The enantiomeric ratio of methyl 9-hydroxystearate was
found to be 90:10 (R:S) by derivatization using (R)-(-)-O-acetylmandelic acid. 9R-HSA is ob-
tained by hydrolyzing this methyl ester. The use of the enantio-enriched product is because it
has been shown that the R-enantiomer is more active as a histone deacetylase inhibitor. These
products were characterized mainly by nuclear magnetic resonance and mass spectrometry.
Since the hydroxyapatite synthesis is carried out in water, the first challenge in this work was
solubilize 9R-HSA in water. This was done by preparing several salts from this acid. Potassium
(9R)-9-hydroxystearate was chosen to be used because it proved to be the most soluble in water
but still depends on high temperatures to be completely solubilized.
Hydroxyapatite (HA) was synthesized by the slow addition of calcium nitrate tetrahydrate
to diammonium hydrogen phosphate in stoichiometric proportions under nitrogen gas flow to
obtain a pure crystalline product. Typically this reaction is carried out by the slow addition
of diammonium hydrogen phosphate to calcium hydrate tetrahydrate but this needed to be
inverted to later include 9R-HSA in the synthesis. This change did not produce significantly
different HA crystals.
9R-HSA was incorporated into HA by the inclusion of potassium (9R)-9-hydroxystearate in
the HA synthesis, mixed with the diammonium hydrogen phosphate. The amount of 9R-HSA
incorporated into HA is a function of the concentration in the reaction solution and it increases
up to 8.58% in weight without precipitation of amorphous material. Coherent domain size and
TEM images show a general decrease in crystal size with the addition of 9R-HSA. This decrease
is more pronounced along the a-axis of the crystals, we can hypothesize that the carboxylate
groups coordinate preferably to the 100 surface of the crystal, where the Ca2+ ions are more
exposed, as has been shown for other carboxylic acids.48 Contact angle measurements showed
that the incorporation of 9R-HSA converts the typically hydrophilic HA into a hydrophobic
material, with a maximum of 91◦ already reached at 4.5% wt 9R-HSA content. Similarly, the
zeta potential also becomes more negative with the addition of 9R-HSA but is close to the
maximum with 4.5% wt 9R-HSA content. Specific surface area measurements do not show
significant changes with the addition of 9R-HSA.
In conclusion, 9R-HSA was successfully incorporated into HA. This has been shown to pro-
voke the variations of several properties of the final apatitic materials, although these variations
are not always proportional to the amount of associated 9R-HSA.
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Annexes
A. Attribution of X-Ray diffraction pattern Bragg reflections
The experimental X-ray diffraction patterns were compared the standards contained in the
International Centre for Diffraction Data (ICDD) database, using the 00-009-0432 card for
synthetic hexagonal hydroxyapatite. This comparison permitted the attribution of the Miller
indices to the experimental Bragg reflections, which was used to determine the unit cell param-
eters.
Table 10: Comparison of experimental Bragg reflections with those contained in ICDD card
00-009-0432.
Miller indices Experimental Reference Miller indices Experimental Reference
h k l 2θ (◦) d (Å) 2 θ (◦) d (Å) h k l 2θ (◦) d (Å) 2 θ (◦) d (Å)
1 0 0 10.80 8.19 10.82 8.17 3 1 0 39.82 2.26 39.82 2.26
1 0 1 16.82 5.27 16.84 5.26 3 1 1 42.02 2.15 42.03 2.15
1 1 0 18.84 4.71 18.78 4.72 1 1 3 43.90 2.06 43.81 2.07
2 0 0 21.80 4.08 21.82 4.07 2 0 3 45.36 2.00 45.30 2.00
1 1 1 22.89 3.89 22.90 3.88 2 2 2 46.73 1.94 46.71 1.94
0 0 2 25.91 3.44 25.88 3.44 3 1 2 48.12 1.89 48.10 1.89
1 0 2 28.22 3.16 28.13 3.17 2 1 3 49.54 1.84 49.47 1.84
2 1 0 28.95 3.13 28.97 3.17 3 2 1 50.51 1.81 50.49 1.81
2 1 1 31.81 2.81 31.77 2.81 4 1 0 51.27 1.78 51.29 1.78
1 1 2 32.20 2.78 32.20 2.78 4 0 2 52.13 1.75 52.10 1.75
3 0 0 32.91 2.72 32.90 2.72 0 0 4 53.25 1.72 53.15 1.72
2 0 2 34.09 2.63 34.05 2.63 3 1 3 57.15 1.61 57.13 1.61
3 0 1 35.48 2.53 35.48 2.53 5 0 1 58.12 1.59 58.08 1.59
2 1 2 39.24 2.30 39.21 2.30
B. Attribution of 13C NMR peaks for 9R-HSA-Me and 9R-HSA
Attribution of the 13C NMR peaks for both methyl (9R)-9-hydroxystearate (9R-HSA-Me) and
(9R)-9-hydroxystearic acid have been attributed based on the values reported by Tulloch.58
The carbon identifications are shown in Figure 37.
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Figure 37: Identification of Carbons used in the 13C NMR attribution.
Table 11: Attribution of the 13C NMR peaks for methyl (9R)-9-hydroxystearate (9R-HSA-Me)
and (9R)-9-hydroxystearic acid (9R-HSA).
Carbon 9R-HSA-Me (ppm) 9R-HSA (ppm)
1 174.1 178.7
2 33.9 33.5
3 24.8 24.8
4 28.9 28.9
5 29.1 29.2
6 29.4 29.4
7 25.4 25.5
8 37.3 37.4
9 71.7 72.0
10 37.4 37.5
11 25.5 25.7
12 29.6 29.7
13 29.56 29.6
14 29.5 29.6
15 29.2 29.2
16 31.8 31.9
17 22.6 22.7
18 14.05 14.1
19 51.3 –
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C. List of Mass Spectrometry peaks of 9R-HSA-Me and 9R-HSA
Table 12: List of Mass Spectrometry peaks of methyl (9R)-9-hydroxystearate (9R-HSA-Me)
and (9R)-9-hydroxystearic acid (9R-HSA). Spectra were obtained by EI-MS.
9R-HSA-Me 9R-HSA
m/z Rel. Height m/z Rel. Height m/z Rel. Height m/z Rel. Height
41.0121 20.54 39.016 2.90 73.0186 20.44 115.0630 2.92
42.9914 5.64 41.0316 26.48 74.0242 1.23 126.0912 3.04
43.0280 19.67 42.0387 5.43 79.0448 1.23 127.0990 10.45
55.0209 31.30 43.0105 5.36 81.0596 5.71 128.1027 1.03
56.9998 7.45 43.0469 25.71 82.0673 8.26 130.0858 1.61
57.0365 10.98 44.0176 2.94 83.0363 1.80 138.1277 3.42
67.0174 11.41 45.0258 3.37 83.0748 23.92 141.0773 4.25
69.0324 17.51 53.0302 1.60 84.0456 5.14 144.1009 15.39
73.9970 33.16 54.0377 3.07 84.0821 3.78 145.1066 2.19
81.0266 6.23 55.0091 2.93 85.0525 1.44 155.0937 100.00
83.0423 17.33 55.0456 36.70 85.0907 2.97 156.0937 9.82
86.9995 49.87 56.0525 6.18 87.0332 4.82 157.1443 3.15
95.0362 5.44 57.0248 9.19 93.0591 1.24 173.1017 13.18
97.0510 7.34 57.0612 13.03 95.0748 5.36 174.1056 1.33
101.0080 8.28 58.0318 1.65 96.0809 2.87 264.2275 1.77
109.0392 13.94 59.0399 2.93 97.0506 2.52
115.0205 17.87 60.0116 9.46 97.0897 9.51
129.0396 6.08 61.0184 1.07 98.0605 21.92
155.0431 100.00 67.0445 12.09 99.0651 1.87
156.0464 10.31 68.0519 5.17 101.0480 10.32
158.0605 52.69 69.0603 22.37 109.0884 15.71
159.0737 11.27 70.0666 3.96 110.0944 2.42
187.0427 45.29 71.0394 3.26 111.0675 2.12
188.0515 5.25 71.0755 4.15 111.1057 1.22
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